Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease
返回论文页
|更新时间:2023-08-29
|
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease
Genes & DiseasesVol. 10, Issue 1, (2023)
作者机构:
1. Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel,Brussels,Belgium,1090
2. Gut-Liver Immunopharmacology Unit, Basic and Applied Medical Sciences
3. Liver Research Centre Ghent
4. Faculty of Medicine and Health Sciences, Ghent University, Ghent,Belgium,9000
5. Hepatology Research Unit, Internal Medicine and Paediatrics
8. Lab of Pharmaceutical Biotechnology, Ghent University, Ghent,Belgium,9000
9. NXTGNT, Ghent University, Ghent,Belgium,9000
10. Department of HPB Surgery and Liver Transplantation, Ghent University Hospital, Ghent,Belgium,9000
11. Department of Pathology, Ghent University Hospital, Ghent,Belgium,9000
Eva Gijbels, Kevin De Muynck, Bart Vanderborght, et al. Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease. [J]. Genes & Diseases 10(1).(2023)
DOI:
Eva Gijbels, Kevin De Muynck, Bart Vanderborght, et al. Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease. [J]. Genes & Diseases 10(1).(2023) DOI: 10.1016/j.gendis.2022.02.003.
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease